BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15755586)

  • 61. What's the matter with HIV-directed killer T cells?
    Wick D; Self SG
    J Theor Biol; 2002 Nov; 219(1):19-31. PubMed ID: 12392972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DermaVir, a novel HIV immunisation technology.
    Lori F; Trocio J; Bakare N; Kelly LM; Lisziewicz J
    Vaccine; 2005 Mar; 23(17-18):2030-4. PubMed ID: 15755566
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Levinson MA
    J Med Primatol; 1999; 28(4-5):249-73. PubMed ID: 10593492
    [No Abstract]   [Full Text] [Related]  

  • 65. Why do we not have an HIV vaccine and how can we make one?
    Burton DR; Moore JP
    Nat Med; 1998 May; 4(5 Suppl):495-8. PubMed ID: 9585194
    [No Abstract]   [Full Text] [Related]  

  • 66. Vaccines against HIV.
    Carmichael AJ; Sissons JG
    QJM; 1995 Feb; 88(2):77-9. PubMed ID: 7704566
    [No Abstract]   [Full Text] [Related]  

  • 67. Cellular and molecular mechanisms of vaccine-induced protection against retroviral infections.
    Dittmer U; Hasenkrug KJ
    Curr Mol Med; 2001 Sep; 1(4):431-6. PubMed ID: 11899087
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [AIDS vaccines: promises and reality].
    Goudsmit J
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1241-5. PubMed ID: 11455689
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DNA vaccines for immunodeficiency viruses.
    Robinson HL
    AIDS; 1997; 11 Suppl A():S109-19. PubMed ID: 9451974
    [No Abstract]   [Full Text] [Related]  

  • 70. DermaVir: a novel topical vaccine for HIV/AIDS.
    Lisziewicz J; Trocio J; Whitman L; Varga G; Xu J; Bakare N; Erbacher P; Fox C; Woodward R; Markham P; Arya S; Behr JP; Lori F
    J Invest Dermatol; 2005 Jan; 124(1):160-9. PubMed ID: 15654970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.
    Florese RH; Wiseman RW; Venzon D; Karl JA; Demberg T; Larsen K; Flanary L; Kalyanaraman VS; Pal R; Titti F; Patterson LJ; Heath MJ; O'Connor DH; Cafaro A; Ensoli B; Robert-Guroff M
    Vaccine; 2008 Jun; 26(26):3312-21. PubMed ID: 18486283
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospects for live attenuated HIV.
    Desrosiers RC
    Nat Med; 1998 Sep; 4(9):982. PubMed ID: 9734368
    [No Abstract]   [Full Text] [Related]  

  • 73. Mechanisms behind the immune response induced by immunostimulating complexes.
    Morein B; Villacrés Eriksson M; Akerblom L; Rönnberg B; Lövgren K; Sjölander A
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S109-14. PubMed ID: 7865283
    [No Abstract]   [Full Text] [Related]  

  • 74. HIV vaccines--where are we going?
    Heilman CA; Baltimore D
    Nat Med; 1998 May; 4(5 Suppl):532-4. PubMed ID: 9585205
    [No Abstract]   [Full Text] [Related]  

  • 75. Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Dolatshahi M
    J Med Primatol; 1994; 23(2-3):184-225. PubMed ID: 7966234
    [No Abstract]   [Full Text] [Related]  

  • 76. Vaccines for the prevention of HIV-1 disease.
    Mascola JR; Nabel GJ
    Curr Opin Immunol; 2001 Aug; 13(4):489-95. PubMed ID: 11498307
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HIV vaccines.
    McMichael AJ
    Annu Rev Immunol; 2006; 24():227-55. PubMed ID: 16551249
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Innate and adaptive mucosal immunity in protection against HIV infection.
    Lehner T
    Vaccine; 2003 Jun; 21 Suppl 2():S68-76. PubMed ID: 12763686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative approach to retroviral vaccines.
    Burny A
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):389-92. PubMed ID: 8882316
    [No Abstract]   [Full Text] [Related]  

  • 80. Cytomegalovirus-vectored vaccines for HIV and other pathogens.
    Barry PA; Deere JD; Yue Y; Chang WWL; Schmidt KA; Wussow F; Chiuppesi F; Diamond DJ; Sparger EE; Walter MR; Hartigan-O'Connor DJ
    AIDS; 2020 Mar; 34(3):335-349. PubMed ID: 31634191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.